FUSEN PHARM (01652) Appoints Zhongzheng Tianheng as New Auditor

Stock News
12/24

FUSEN PHARM (01652) announced that KPMG has resigned as the company's auditor effective December 24, 2025, due to the board's failure to reach an agreement on proposed audit fees for the group's consolidated financial statements for the fiscal year ending December 31, 2025. Upon the recommendation of the audit committee, Zhongzheng Tianheng Certified Public Accountants Co., Ltd. has been appointed as the new auditor to fill the vacancy left by KPMG. The appointment takes effect from December 24, 2025, and will remain valid until the conclusion of the company's next annual general meeting.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10